Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia

Brain

Volumn 137, Issue 5, 2014, Pages 1524-1532

  Barker, Rachel ^a   Ashby, Emma L ^a   Wellington, Dannielle ^a   Barrow, Vivienne M ^a   Palmer, Jennifer C ^a   Kehoe, Patrick G ^a   Esiri, Margaret M ^b   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; brain ischaemia; cerebral blood flow; dementia; neuropathology

Indexed keywords

ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; MYELIN ASSOCIATED GLYCOPROTEIN; PROTEOLIPID PROTEIN; VASCULOTROPIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UNITED KINGDOM; UPREGULATION; VERY ELDERLY; WHITE MATTER;

ALZHEIMER'S DISEASE; BRAIN ISCHAEMIA; CEREBRAL BLOOD FLOW; DEMENTIA; NEUROPATHOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COHORT STUDIES; DEMENTIA, VASCULAR; ENDOTHELIN-1; FACTOR VIII; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE FIBERS, MYELINATED; PEPTIDYL-DIPEPTIDASE A; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899847826     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu040     Document Type: Article

References (41)

1. Ashby EL, Kehoe PG, Love S. Kallikrein-related peptidase 6 in Alzheimers disease and vascular dementia. Brain Res 2010; 1363: 1-10.
2. Barker R, Wellington D, Esiri MM, Love S. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 2013; 33: 1050-7.
3. Barone FC, Globus MY, Price WJ, White RF, Storer BL, Feuerstein GZ, et al. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Flow Metab 1994; 14: 337-42.
4. Bian LG, Zhang TX, Zhao WG, Shen JK, Yang GY. Increased endothelin- 1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett 1994; 174: 47-50.
5. Eckman EA, Reed DK, Eckman CB. Degradation of the Alzheimers amyloid b peptide by endothelin-converting enzyme. J Biol Chem 2001; 276: 24540-8.
6. Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB. Alzheimers disease b-amyloid peptide is increased in mice deficient in endothelin- converting enzyme. J Biol Chem 2003; 278: 2081-4.
7. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimers disease: the CERAD experience, part XV. Neurology 1996; 46: 1592-6.
8. Erdös EG, Skidgel RA. The angiotensin I-converting enzyme. Lab Invest 1987 56 345
9. Estrada V, Téllez MJ, Moya J, Fernández-Durango R, Egido J, Fernández Cruz A. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens 1994; 7: 1085-9.
10. Harrigan MR, Ennis SR, Sullivan SE, Keep RF. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir 2003; 145: 49-53.
11. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998; 18: 887-95.
12. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344: 852-4.
13. Hemming ML, Selkoe DJ. Amyloid b-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 2005; 280: 37644-50.
14. Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid b-peptide (Ab); retards Ab aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 2001; 276: 47863-8.
15. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimers disease. Nat Rev Neurosci 2004; 5: 347-60.
16. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest 1999; 79: 417-25.
17. Jagust JW, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987; 44: 258-62.
18. Kalaria RN. The role of cerebral ischemia in Alzheimers disease. Neurobiol Aging 2000; 21: 321-30.
19. Kalaria RN, Cohen DL, Premkumar DRD, Nag S, LaManna JC, Lust WD. Vascular endothelial growth factor in Alzheimers disease and experimental cerebral ischemia. Mol Brain Res 1998; 62: 101-5.
20. Krum JM, Mani N, Rosenstein JM. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002; 110: 589-604.
21. Lampl Y, Fleminger G, Gilad R, Galron R, Sarova-Pinhas I, Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke 1997; 28: 1951-5.
22. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 50 enhancer. Circ Res 1995; 77: 638-43.
23. Love S, Nicoll JAR, Hughes A, Wilcock GK. APOE and cerebral amyloid angiopathy in the elderly. Neuroreport 2003; 14: 1535-6.
24. Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, et al. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimers disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2008; 34: 181-93.
25. Oba R, Igarashi A, Kamata M, Nagata K, Takano S, Nakagawa H. The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid b-peptide. Eur J Neurosci 2005; 21: 733-40.
26. Ohtaki H, Fujimoto T, Sato T, Kishimoto M, Fujimoto M, Moriya M, et al. Progressive expression of vascular endothelial growth factor (VEGF) and angiogenesis after chronic ischemic hypoperfusion in rat. Acta Neurochir Suppl 2006; 96: 283-7.
27. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimers disease and Lewy body variant. Neurology 1996; 47: 190-6.
28. Palmer JC, Barker R, Kehoe PG, Love S. Endothelin-1 is elevated in Alzheimers disease and upregulated by amyloid-b. J Alz Dis 2012; 29: 853-61.
29. Palmer JC, Tayler HM, Love S. Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimers disease. J Alz Dis 2013; 36: 577-87.
30. Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cereb Brain Metab Rev 1990; 2: 161-92.
31. Rosenstein JM, Mani N, Silverman WF, Krum JM. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 7086-91.
32. Schuff N, Matsumoto S, Kmiecik J, Studholme C, Du A, Ezekiel F, et al. Cerebral blood flow in ischemic vascular dementia and Alzheimers disease, measured by arterial spin-labeling magnetic resonance imaging. Alz Dement 2009; 5: 454-62.
33. Sharp P, Gemmell H, Cherryman G, Besson J, Crawford J, Smith F. Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. J Nucl Med 1986; 27: 761-8.
34. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-5.
35. Sun Y, Jin K, Xie L, Childs J, Maxo XO, Loqvinova A, et al. VEGFinduced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111: 1843-51.
36. Tarkowski E, Issa R, Sjögren M, Wallin A, Blennow K, Tarkowski A, et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-b in Alzheimers disease and vascular dementia. Neurobiol Aging 2002; 23: 237-43.
37. Viossat I, Duverger D, Chapelat M, Pirotzky E, Chabrier PE, Braquet P. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol 1993; 22: S306-S9.
38. Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda Si, et al. Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 2000; 105: 1373-82.
39. Yang SP, Bae DG, Kang HJ, Gwag BJ, Gho YS, Chae CB. Co-accumulation of vascular endothelial growth factor with b-amyloid in the brain of patients with Alzheimers disease. Neurobiol Aging 2004; 25: 283-90.
40. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106: 829-38.
41. Ziv I, Fleminger G, Djaldetti R, Achiron A, Melamed E, Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke 1992; 23: 1014-6.